Apollomics Inc. (APLMW)
NASDAQ: APLMW
· Real-Time Price · USD
0.02
-0.00 (-19.68%)
At close: May 30, 2025, 3:28 PM
0.02
0.00%
After-hours: May 30, 2025, 04:00 PM EDT
Company Description
Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs.
The company was founded by Liang Yu Guo and Sanjeev Redkar in 2015 and is headquartered in Foster City, CA.
Apollomics Inc.
| Country | United States |
| IPO Date | Mar 30, 2023 |
| Industry | Financial - Conglomerates |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Guo-Liang Yu |
Contact Details
Address: No Address available Foster City, United States | |
| Website | http://www.apollomicsinc.com |
Stock Details
| Ticker Symbol | APLMW |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001944885 |
| CUSIP Number | n/a |
| ISIN Number | KYG0411D1152 |
| Employer ID | 00-0000000 |
| SIC Code | 2834 |
Key Executives
No executives data available.Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 03, 2025 | 20-F | Filing |
| Apr 03, 2025 | 6-K | Filing |
| Mar 31, 2025 | 6-K | Filing |
| Jan 10, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| Dec 20, 2024 | 6-K | Filing |
| Dec 10, 2024 | 6-K | Filing |
| Nov 14, 2024 | 6-K | Filing |
| Nov 01, 2024 | 6-K | Filing |
| Aug 15, 2024 | SC 13D/A | [Amend] Filing |
| Aug 14, 2024 | 6-K | Filing |